These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21120565)

  • 1. Retrospective survey on the off-label use of posaconazole in pediatric hematology patients.
    Cesaro S; Milano GM; Aversa F
    Eur J Clin Microbiol Infect Dis; 2011 Apr; 30(4):595-6. PubMed ID: 21120565
    [No Abstract]   [Full Text] [Related]  

  • 2. Posaconazole: new indications. Prevention of invasive mycosis and treatment of oropharyngeal candidiasis: no therapeutic advantage.
    Prescrire Int; 2008 Dec; 17(98):233. PubMed ID: 19422144
    [No Abstract]   [Full Text] [Related]  

  • 3. Understanding antifungal prophylaxis with posaconazole in hematology patients: an evolving bedside to bench story.
    Sheppard DC; Campoli P; Duarte RF
    Haematologica; 2014 Apr; 99(4):603-4. PubMed ID: 24688107
    [No Abstract]   [Full Text] [Related]  

  • 4. Numbers needed to treat with posaconazole prophylaxis to prevent invasive fungal infection and death.
    Cornely OA; Ullmann AJ
    Clin Infect Dis; 2008 May; 46(10):1626-7; author reply 1627-8. PubMed ID: 18419501
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-world experience with posaconazole prophylaxis in high-risk hematological patients in Singapore: a prospective audit.
    Low CY; Ong WC; Wong E; Ding Y; Diong CP; Jin J; Lim ZY; Hsu LY
    J Infect; 2013 Mar; 66(3):291-4. PubMed ID: 23201153
    [No Abstract]   [Full Text] [Related]  

  • 6. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal.
    Uzun O; Anaissie EJ
    Blood; 1995 Sep; 86(6):2063-72. PubMed ID: 7662953
    [No Abstract]   [Full Text] [Related]  

  • 8. Posaconazole salvage treatment in paediatric patients: a multicentre survey.
    Lehrnbecher T; Attarbaschi A; Duerken M; Garbino J; Gruhn B; Kontny U; Lüer S; Phillips R; Scholz J; Wagner HJ; Wiesel T; Groll AH
    Eur J Clin Microbiol Infect Dis; 2010 Aug; 29(8):1043-5. PubMed ID: 20495990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of posaconazole in children: Experience in a tertiary pediatric hospital].
    Rosanova MT; Voto C; Mussini MS; Sarkis C; Gómez S; Sberna N; Carnovale S; Caracciolo B; Lede R
    Arch Argent Pediatr; 2018 Jun; 116(3):e451-e454. PubMed ID: 29756722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
    Papy E; Carde A; Ribaud P; Faure P; Touratier S
    Presse Med; 2006 Feb; 35(2 Pt 1):251-2. PubMed ID: 16493359
    [No Abstract]   [Full Text] [Related]  

  • 11. [Level of evidence for therapeutic drug monitoring of posaconazole].
    Lefeuvre S; Jelassi ML; Benlmouden A; Berge M; Le Guellec C; Billaud EM;
    Therapie; 2011; 66(2):115-22. PubMed ID: 21635858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antifungal drugs and the pediatric cancer patient: current status of clinical development.
    Groll AH; Lehrnbecher T
    Klin Padiatr; 2005; 217(3):158-68. PubMed ID: 15858708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posaconazole.
    Keating GM
    Drugs; 2005; 65(11):1553-67; discussion 1568-9. PubMed ID: 16033292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.
    Raad II; Graybill JR; Bustamante AB; Cornely OA; Gaona-Flores V; Afif C; Graham DR; Greenberg RN; Hadley S; Langston A; Negroni R; Perfect JR; Pitisuttithum P; Restrepo A; Schiller G; Pedicone L; Ullmann AJ
    Clin Infect Dis; 2006 Jun; 42(12):1726-34. PubMed ID: 16705579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience.
    Jeong W; Haywood P; Shanmuganathan N; Lindsay J; Urbancic K; Ananda-Rajah MR; Chen SC; Bajel A; Ritchie D; Grigg A; Seymour JF; Peleg AY; Kong DC; Slavin MA
    J Antimicrob Chemother; 2016 Dec; 71(12):3540-3547. PubMed ID: 27521358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A twice daily posaconazole dosing algorithm for children with chronic granulomatous disease.
    Welzen ME; Brüggemann RJ; Van Den Berg JM; Voogt HW; Gilissen JH; Pajkrt D; Klein N; Burger DM; Warris A
    Pediatr Infect Dis J; 2011 Sep; 30(9):794-7. PubMed ID: 21772229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from posaconazole suspension to tablets increases serum drug levels in leukemia patients without clinically relevant hepatotoxicity.
    Jung DS; Tverdek FP; Kontoyiannis DP
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6993-5. PubMed ID: 25199774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Posaconazole: another triazole antifungal of the new generation?].
    Müller C; Kohl V; Farowski F; Cornely OA
    Dtsch Med Wochenschr; 2008 Nov; 133(45):2345-8. PubMed ID: 18958831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.